<DOC>
	<DOCNO>NCT00785083</DOCNO>
	<brief_summary>This study evaluate effect FTY720 lung function patient moderate asthma</brief_summary>
	<brief_title>A Study Effect FTY720 Pulmonary Function Patients With Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Forced Expiratory Volume 1 second least 60 % History asthma least 6 month Current use shortacting beta agonist , inhale longacting beta agonist inhale corticosteroid ( specify dose ) History lung disease asthma Smokers Use inhale corticosteroid specify dose Use oral beta agonist corticosteroids asthma medication Hypersensitivity drug Respiratory tract infection within 1 month study Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Asthma , adrenergic beta agonist , multiple sclerosis , pulmonary function test , force expiratory volume</keyword>
</DOC>